FGF2 and depressive symptom measurement: Woodbury et al. found that microglia cells were hyperactivated in CUMS rats, and miR-497 aggravated hippocampal microglia activation by targeting FGF2, suggesting that miR-497 might represent a potential target for the treatment of depression [73].